期刊文献+

同系大鼠骨髓间充质干细胞对同种异体胰岛刺激的T淋巴细胞的免疫调节作用

The immunoregulation of syngenic bone marrow mesenchymal stem cells on allogenic islets induced T lymphocytes
下载PDF
导出
摘要 目的:研究同系大鼠骨髓间充质干细胞(Mesenchymal stem cell,MSC)对同种异体胰岛刺激的T淋巴细胞的免疫调节作用,以及对共培养胰岛胰岛素分泌的影响。方法:以Wistar大鼠胰岛作为刺激原,Lewis大鼠MSC及外周血T淋巴细胞作为共培养细胞,分为三组:实验组(A)20IEQ胰岛细胞、1×108 L-1 T淋巴细胞和1×107 L-1 MSCs共培养;药物对照组(B)20IEQ胰岛细胞与1×108 L-1 T淋巴细胞共培养并加入0.25μg/ml CsA;阳性对照组(C)20IEQ胰岛细胞与1×108 L-1 T淋巴细胞共培养。CCK-8检测共培养3天时T淋巴细胞对同种异体胰岛刺激的反应性,ELISA检测共培养3天时上清液IFN-γ、IL-2、IL-4和IL-10的含量,以及共培养胰岛的胰岛素分泌功能。结果:MSC与CsA均可抑制同种异体胰岛刺激的T淋巴细胞增殖,A组T淋巴细胞增殖率(17.10±2.7)%与B组(14.65±1.8)%间差异无统计学意义(P>0.05);C组IFN-γ、IL-2含量显著高于A组及B组,IL-10含量显著低于A及B组,差异有统计学意义(P<0.05);IL-4含量在A、B、C三组间差异均无统计学意义(P>0.05)。A组胰岛的胰岛素分泌水平显著高于B组和C组,差异有统计学意义(P<0.05);胰岛素刺激指数(2.37±0.52)显著高于B组(1.80±0.36),差异有统计学意义(P<0.05)。结论:MSC与CsA均可通过减少Th1类细胞因子的表达使受者Th1/Th2平衡向Th2方向偏移,抑制同种异体胰岛刺激的T淋巴细胞增殖。相对于CsA,MSC可以保持胰岛素高分泌水平和良好的糖刺激反应性,避免了CsA可能带来的毒性和副作用,具有一定的临床应用优势及前景。 Objective:To observe the immunoregulation of syngenic bone marrow mesenchymal stem cells(MSCs) on T lymphocytes,which induced by allogenic islets,and to further observe the influence on insulin secretion of islets.Methods:Isolated islets from Wistar rats as the stimulator.MSCs and T lymphocytes were isolated from Lewis rats.Experimental group(A): the coculture system of 20IEQ islets,1×108 L-1 T lymphocytes and 1×107 L-1 MSCs;Drug group(B): 20IEQ islets cocultured with 1×108 L-1 T lymphocytes then added 0.25 μg/ml CsA;the control group(C): 20IEQ islets cocultured with 1×108 L-1 T lymphocytes.The proliferation of T lymphocytes was measured by CCK-8 assay on day 3.The concentration of IFN-γ,IL-2,IL-4 and IL-10 were detected by ELISA on day 3,as well as insulin.Results:Both MSC and CsA inhibited T lymphocytes proliferation,and there was no significant difference between group A(17.10±2.7)% and group B(14.65±1.8)%(P0.05);the concentration of IFN-γ and IL-2 in group C was significantly higher than group A and B.IL-2,on the contrary,was lower in group C(P0.05);there was no significant difference of IL-4 in group A,B and C(P0.05);the concentration of insulin in group A was higher than group B and C(P0.05);the stimulate index of insulin in group A(2.37±0.52)was higher than group B(1.80±0.36,P0.05).Conclusion:MSC and CsA,due to the ability of changing cytokine secretion and affecting the balance of Th1/Th2 to Th2,reduced the proliferation of allogenic islets induced T lymphocytes.MSC could maintain a higher level of insulin secretion as well as insulin response to glucose,compared to CsA.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2012年第4期328-332,共5页 Chinese Journal of Immunology
基金 中国博士后科学基金面上资助(20080440910)项目 黑龙江省卫生厅科研课题(2009-149)
关键词 骨髓间充质干细胞 胰岛 环孢素A TH1/TH2 Mesenchymal stem cells Islet Cyclosporine A Th1/ Th2
  • 相关文献

参考文献2

二级参考文献63

  • 1乌仁娜,姚志娟,楼晓,毕东杰,黄云中,冯凯,陈虎.骨髓间充质干细胞对异体T细胞几种细胞因子分泌的影响[J].中国免疫学杂志,2006,22(5):426-430. 被引量:8
  • 2Robertson RP.Islet Transplantation as a Treatment for Diabetes-A Work in Progress.N Engl J Med 2004;350;694-705.
  • 3Ballinger WF,Lacy PE.Transpantation of intact Pancreatic islets in rats.Surgery 1972;72;175-186.
  • 4Reckard CR,Ziegler MM,Barker CF.Physiological and immunological consequences of transplanting isolated pancreatic islets.Surgery,1773;74;91-99.
  • 5Thomas DR,Fox M,Grieve AA.Isolation of islets of Langerhans for transplantation.Nature,1973;242;258-260.
  • 6Alejandro R,Lehmann R,Riccordi C,Kenyon NS,Angelico MC,Burke G,Esquenazi V,Nery J,Betancourt AE,Kong SS,Miller j,Mintz DH.Long-term function (6 years) of islet allografts in type 1 diabetes.Diabetes,1997;46;1983-1989.
  • 7Oberholzer J,Triponez F,Mage R,Andereggen E,Buhler L,Cretin N,Fournier B,Goumaz C,Lou J,Philippe J,Morel P.Human islet transplantation:lessons From 13 autologous and 13 allogeneic transplantation.Transplantation.2000;69;1115-1123.
  • 8Shapiro AM,Lakey JR,Ryan EA,Korbutt GS,Toth E,Warnock GL,Kneteman NM,Rajotte RV.Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.N Engl J Med 2000;343;230-238.
  • 9Ryan EA,Lakey JR,Rajotte RV,Korbutt GS,Kin T,Imes S,Rabinovitch A,Elliott JF,Bigam D,Kneteman NM,Warnock GL,Larsen I,Shapiro AM,Clinisal outcomes and insulin secretion after islet transplantation with the Edmonton Protocol.Diabetes,2001;50;710-719.
  • 10Hirshberg B,Rother KI,Digon BJ 3rd,Lee J,Gaglia JL,Hines K,Read EJ,Chang R,Wood BJ.Harlan DM,Benefits and risks of solitary islet transplantation for Type 1 diabetes using steroilsparing immunosuppression.Diabetes Care 2003;26;3288-3292.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部